Prenatal screening for congenital heart disease using real-time three-dimensional echocardiography and a novel 'sweep

M Sklansky1, D Miller, G Devore

  • 1University of Southern California, Keck School of Medicine, Los Angeles, CA, USA. msklansky@chla.usc.edu

Insights

Real-time three-dimensional echocardiography (RT3DE) shows promise for screening congenital heart disease (CHD) in fetuses, offering high sensitivity but requiring artifact reduction and improved resolution for clinical use.

Area of Science:

  • Medical imaging
  • Cardiology
  • Prenatal diagnostics

Background:

  • Conventional prenatal screening for congenital heart disease (CHD) is operator-dependent and time-consuming.
  • Real-time three-dimensional echocardiography (RT3DE) offers rapid acquisition of the entire fetal heart.
  • RT3DE may streamline fetal cardiac screening.

Purpose of the Study:

  • To evaluate the potential of RT3DE as a screening tool for fetal CHD.
  • To assess the sensitivity and specificity of RT3DE in detecting fetal CHD.
  • To identify limitations of RT3DE for prenatal cardiac assessment.

Main Methods:

  • Four experienced reviewers independently evaluated cardiac volumes from 18 fetuses (11 normal, 7 with CHD).
  • Two-dimensional echocardiography was used as the gold standard.
  • A 'sweep volume' technique was employed for RT3DE acquisition (2-6 seconds per volume).

Main Results:

  • RT3DE demonstrated high sensitivity (93%) for detecting CHD.
  • Specificity for CHD detection was low (45%), with frequent 'cannot determine' responses.
  • False positive artifacts were noted, impacting specificity.

Conclusions:

  • RT3DE shows potential as a screening tool for fetal heart disease.
  • Minimizing artifacts and improving resolution are crucial for clinical application.
  • Significant training is required before widespread adoption of RT3DE for fetal cardiac screening.
Abstract